Erlotinib/gefitinibDevelopment of resistance in EGFR-mutated NSCLC patients: 8 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2015年 / 1540卷 / 1期
关键词：
D O I：
10.1007/s40278-015-7978-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：130 / 130
相关论文
共 50 条
  • [1] Erlotinib/gefitinibDevelopment of resistance to erlotinib and gefitinib: 3 case reports
    [J]. Reactions Weekly, 2018, 1730 (1) : 136 - 136
  • [2] Resistance landscape to almonertinib in EGFR-mutated NSCLC
    Tian, M.
    Lu, Z.
    Chen, S.
    Lu, G.
    Bu, F.
    Deng, W.
    Ding, R.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1017 - S1017
  • [3] Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model
    Masuda, Chinami
    Yanagisawa, Mieko
    Yorozu, Keigo
    Kurasawa, Mitsue
    Furugaki, Koh
    Ishikura, Nobuyuki
    Iwai, Toshiki
    Sugimoto, Masamichi
    Yamamoto, Kaname
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) : 425 - 434
  • [4] Liquid and Solid Rebiopsies in EGFR-Mutated NSCLC Patients
    Nunes, D.
    Dansin, E.
    Lamblin, C.
    Wasielewski, E.
    Descarpentries, C.
    Gregoire, V.
    Copin, M. C.
    Escande, F.
    Cortot, A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2237 - S2238
  • [5] GefitinibDevelopment of gefitinib resistance in EGFR mutated lung adenocarcinoma: case report
    [J]. Reactions Weekly, 2017, 1675 (1) : 117 - 117
  • [6] Erlotinib/gefitinibDevelopment of resistance in stage IV adenocarcinoma: 7 case reports
    [J]. Reactions Weekly, 2018, 1724 (1) : 159 - 159
  • [7] Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    Wu, Yi-Long
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (14): : 1341 - 1342
  • [8] Osimertinib in EGFR-Mutated Advanced NSCLC
    Staege, Martin S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19): : 1863 - +
  • [9] Gefitinib Approved for EGFR-Mutated NSCLC
    不详
    [J]. CANCER DISCOVERY, 2015, 5 (09) : 896 - 896
  • [10] Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic EGFR-Mutated NSCLC: RELAY Japanese Subset
    Nishio, Kazuto
    Seto, Takashi
    Nishio, Makoto
    Reck, Martin
    Garon, Edward B.
    Sakai, Kazuko
    Goto, Koichi
    Kato, Terufumi
    Nakanishi, Yoichi
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Kiura, Katsuyuki
    Ohe, Yuichiro
    Tamura, Tomohide
    Visseren-Grul, Carla
    Frimodt-Moller, Bente
    Hozak, Rebecca R.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
12345